Physician

Saad Yousuf, M.D.

According to 2025 Medicare claims, Saad Yousuf, M.D. (NPI: 1477814960) practices internal medicine in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is OPTUM MEDICAL CARE, P.C. (NPI: 1982643003; TIN: 133544120) and primary practice location at 12601-9998. Yousuf is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Yousuf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 574 traditional Medicare patients, billed 164,926 HCPCS/CPT codes, and received $2,389,526 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,598 prescription claims across 316 beneficiaries totaling $4,622,964 in drug costs, led by Kisqali (Ribociclib Succinate). 2020 DME data shows 31 claims. Open Payments data shows 6 records totaling $151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,754 to $2,389,526. Similarly, Part D prescription costs have moved sharply higher in recent years, from $24,951 to $4,622,964. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	22	22	$3,754
2016	30	30	$5,127
2017	N/R	N/R	N/R
2018	123	15,211	$96,841
2019	447	91,041	$722,799
2020	519	114,348	$1,506,034
2021	570	139,078	$2,041,539
2022	617	166,555	$2,276,799
2023	541	203,994	$2,444,824
2024	574	164,926	$2,389,526

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	14	28	$24,951
2019	118	791	$695,757
2020	174	1,025	$1,335,267
2021	215	1,270	$2,474,306
2022	273	1,394	$3,254,414
2023	294	1,577	$4,018,712
2024	316	1,598	$4,622,964

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	31	$2,383
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	298	564	$100
80053	Blood test, comprehensive group of blood chemicals	182	501	$10
36415	Insertion of needle into vein for collection of blood sample	376	1,153	$9
83550	Iron binding capacity	146	241	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	309	854	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kisqali	Ribociclib Succinate	35	980	$593,898
Ibrance	Palbociclib	39	1,092	$580,613
Keytruda	Pembrolizumab	24	567	$377,262
Lenalidomide	Lenalidomide	27	672	$332,963
Brukinsa	Zanubrutinib	19	570	$285,293

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$151	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Saad Yousuf, M.D.?

Tedicare shows public-source Medicare data for Saad Yousuf, M.D. (NPI 1477814960), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Saad Yousuf, M.D. have ACO affiliation data?

Saad Yousuf, M.D. is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Saad Yousuf, M.D.?

Saad Yousuf, M.D. is linked to OPTUM MEDICAL CARE, P.C. (billing NPI 1982643003) in the available physician profile data.

Does Saad Yousuf, M.D. have Open Payments data?

Saad Yousuf, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.